PUMPKINSEED TECHNOLOGIES INC

Biotech · Private

Cell-MAPP: a live-cell monitoring platform that tracks individual T cell states and dynamics during antigen exposure, coupling continuous flow-cytometry-like readouts with TCR sequencing.

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Total capital
$2.2M
Federal grants
$2.2M
4 awards · 2023–2025
Rank in peer group#40 of 42
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
10 pending

Capital timeline

202320242025FEDERAL ↑EQUITY ↓Cumulative $2.2M$275K$290K$353K$1.2M
202320242025FEDERAL ↑EQUITY ↓Cumulative $2.2M$275K$290K$353K$1.2M

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: High-throughput De-novo Peptide Sequencing with Metasurface Optics$1.2M
  • Federal grantHealth and Human S · Phase I · Dynamic, live-cell monitoring of T-cell states against presented peptides$353K
  • Federal grantHealth and Human S · Phase I · Vibrational spectroscopy with metasurface optics (VISMO) for high-throughput identification of protein post-translational modifications$290K
  • Federal grantNSF · Phase I · SBIR Phase I: Developing Vibrational spectroscopy with metasurface optics (VISMO) for label-free, high-resolution, high-throughput protein screening$275K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Biotech · Instrument

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 10
  • PendingMethods And Systems For Label-free Analyte DetectionUSPTOApplication 19146436
  • PendingMethods And Systems For Nucleic Acid Sequence DeterminationUSPTOApplication PCTUS2025013247
  • PendingLabel-free Sequencing Approaches And Applications For Heterogeneous SamplesUSPTOApplication PCTUS2025013243
Show all 10 patent records
  • Methods And Systems For Label-free Analyte DetectionApplication 19146436Pending
  • Methods And Systems For Nucleic Acid Sequence DeterminationApplication PCTUS2025013247Pending
  • Label-free Sequencing Approaches And Applications For Heterogeneous SamplesApplication PCTUS2025013243Pending
  • Methods And Systems For Label-free De Novo SequencingApplication PCTUS2024022689Pending
  • Methods And Systems For Nucleic Acid Sequence DeterminationApplication 63625848Pending
  • Label-free Sequencing Approaches And Applications For Heterogeneous SamplesApplication 63625880Pending
  • Methods And Systems For Label-free Analyte DetectionApplication PCTUS2024010744Pending
  • Methods And Systems For Analyte DetectionApplication 63493949Pending
  • Methods And Systems For Analyte DetectionApplication 63479165Pending
  • Methods And Systems For Label-free De Novo SequencingApplication 19472034Pending
  • SYGNAMAP, INC.Similar federal contract value in Biotech · null in contracts
  • Antheia, Inc.Similar federal contract value in Biotech · null in contracts
  • BIOMESENSE, INC.Similar federal contract value in Biotech · null in contracts
  • EXHALIX, LLCSimilar federal contract value in Biotech · null in contracts
  • Bondwell Technologies LPSimilar federal contract value in Biotech · null in contracts
  • CERIA THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .